Related Experiment Video
Updated: Jan 23, 2026

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Emerging Concepts in Precision Medicine and Cardiovascular Diseases in Racial and Ethnic Minority Populations
George A Mensah1, Cashell Jaquish2, Pothur Srinivas2
1From the Center for Translation Research and Implementation Science (G.A.M., M.C.G.P., W.B., K.N.F., C.A.B., M.M.E.), National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
Insights
Precision cardiovascular medicine can reduce health disparities in minority populations. Ensuring diversity in genomics research and using ancestry-matched controls are crucial for accurate risk assessment and effective prevention strategies.
Area of Science:
- Cardiovascular Disease
- Precision Medicine
- Genomics
- Health Disparities
Background:
- Cardiovascular diseases are a leading cause of death globally, with known risk factors impacting all populations.
- Social, environmental, genetic, and epigenetic factors significantly influence cardiovascular risk, particularly in racial and ethnic minorities.
- Current cardiovascular disease prevention and treatment strategies are foundational for public health.
Purpose of the Study:
- To review emerging concepts in precision medicine for cardiovascular disease in racial and ethnic minority populations.
- To highlight challenges and opportunities in genomics research, including diversity and variant interpretation.
- To examine the role of epigenetics, pharmacogenomics, and genetic counseling in addressing disparities.
Main Methods:
- Review of current literature on precision medicine and cardiovascular disease in minority populations.
- Examination of genomics study diversity, biorepositories, and variant interpretation methodologies.
- Analysis of social, cultural, and ethical implications of precision medicine.
Main Results:
- Lack of diversity in genomics studies leads to misclassification of genetic variants in minority populations.
- Ancestry-matched controls are essential for accurate genetic variant interpretation.
- Precision medicine holds potential to reduce racial and ethnic disparities in cardiovascular disease.
Conclusions:
- Implementing precision medicine in cardiovascular disease requires addressing diversity and inclusion in genomics research.
- Strategies must incorporate ancestry-matched controls and consider broader social determinants of health.
- Large-scale research programs like NIH's All of Us and NHLBI's TOPMed are advancing precision medicine for diverse populations.
Abstract:
Cardiovascular diseases remain the leading cause of mortality and a major contributor to preventable deaths worldwide. The dominant modifiable risk factors and the social and environmental determinants that increase cardiovascular risk are known, and collectively, are as important in racial and ethnic minority populations as they are in majority populations. Their prevention and treatment remain the foundation for cardiovascular health promotion and disease prevention. Genetic and epigenetic factors are increasingly recognized as important contributors to cardiovascular risk and provide an opportunity for advancing precision cardiovascular medicine. In this review, we explore emerging concepts at the interface of precision medicine and cardiovascular disease in racial and ethnic minority populations. Important among these are the lack of racial and ethnic diversity in genomics studies and biorepositories; the resulting misclassification of benign variants as pathogenic in minorities; and the importance of ensuring ancestry-matched controls in variant interpretation. We address the relevance of epigenetics, pharmacogenomics, genetic testing and counseling, and their social and cultural implications. We also examine the potential impact of precision medicine on racial and ethnic disparities. The National Institutes of Health's All of Us Research Program and the National Heart, Lung, and Blood Institute's Trans-Omics for Precision Medicine Initiative are presented as examples of research programs at the forefront of precision medicine and diversity to explore research implications in minorities. We conclude with an overview of implementation research challenges in precision medicine and the ethical implications in minority populations. Successful implementation of precision medicine in cardiovascular disease in minority populations will benefit from strategies that directly address diversity and inclusion in genomics research and go beyond race and ethnicity to explore ancestry-matched controls, as well as geographic, cultural, social, and environmental determinants of health.
Related Concept Videos
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Minor Losses in Pipes
Valves play a significant role in generating minor losses by obstructing or redirecting the fluid flow. When a valve is closed or partially closed, it restricts the flow...
Ethnic Identity within a Larger Culture
Self-Concept
Infancy and Emerging Recognition
During infancy, self-concept is virtually nonexistent. Babies do not distinguish themselves as separate entities and often mistake their...
Emerging Adulthood
Conservation of Small Populations

